Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00079092
Status:
COMPLETED
Last Update Posted:
2021-09-09
First Post:
2004-03-08
Brief Title:
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
Wake Forest University Health Sciences
Organization:
Wake Forest University Health Sciences
Organization Data
Organization:
Wake Forest University Health Sciences
Class:
OTHER
Study ID:
REBACDR0000354204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wake Forest University Health Sciences
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |